A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia

Background: Darbepoetin alfa is the second erythropoietic protein to be approved for the treatment of chemotherapy-induced anemia (CIA). In the clinical setting, darbepoetin alfa can be administered less frequently than epoetin alfa with similar efficacy. Practice patterns and outcomes associated wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2003-11, Vol.25 (11), p.2781-2796
Hauptverfasser:	Schwartzberg, Lee, Shiffman, Roger, Tomita, Dianne, Stolshek, Bradley, Rossi, Greg, Adamson, Robert
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Anemia Anemia - chemically induced Anemia - drug therapy Antineoplastic Agents - adverse effects Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system Cancer Chemotherapy Clinical trials Darbepoetin alfa Drug Administration Schedule Drug dosages Drug Utilization Review Epoetin Alfa erythropoiesis Erythropoietin - administration & dosage Erythropoietin - analogs & derivatives Erythropoietin - therapeutic use Female Hematinics - administration & dosage Hematinics - therapeutic use hemoglobin Humans Lymphoma Male Medical sciences Middle Aged Multiple myeloma Neoplasms - drug therapy Observational studies Oncology Pharmacoeconomics Pharmacology. Drug treatments Practice Patterns, Physicians Proteins Quality of life Recombinant Proteins Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!